Introduction: Pachydermoperiostosis or primary hypertrophic osteoathropathy is a rare genetic disease with autosomal transmission. This disorder, which affects both bones and skin, is characterized by the association of dermatologic changes (pachydermia or thickening of the skin) and rheumatologic manifestations (periostosis and finger clubbing). Here, we report a new observation of pachydermoperiostosis.

Case Presentation: A 20-year-old North African Tunisian Caucasian man presented with hypertrophic osteoarthropathy. On a clinical examination, we found morphologic abnormalities of his face and extremities associated with skin changes. The laboratory findings were normal. A work-up disclosed no organic etiology. The final diagnosis consisted of pachydermoperiostosis syndrome.

Conclusion: Pachydermoperiostosis is a rare entity that should be differentiated from secondary hypertrophic osteoarthropathy and chronic rheumatic diseases.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3277474PMC
http://dx.doi.org/10.1186/1752-1947-6-31DOI Listing

Publication Analysis

Top Keywords

hypertrophic osteoarthropathy
12
primary hypertrophic
8
hypertrophy feet
4
feet ankles
4
ankles presenting
4
presenting primary
4
hypertrophic
4
pachydermoperiostosis
4
osteoarthropathy pachydermoperiostosis
4
pachydermoperiostosis case
4

Similar Publications

Hypertrophic osteoarthropathy (HOA: MIM 167100)) is classified into primary and secondary types. Primary HOA, also known as pachydermoperiostosis (PDP), is a rare genetic condition with distinct clinical features including digital clubbing, skin thickening, and periostosis. Secondary HOA often occurs as a paraneoplastic syndrome or is associated with systemic diseases.

View Article and Find Full Text PDF

Targeting Metabolomics in Primary Hypertrophic Osteoarthropathy: Uncovering Novel Insights into Disease Pathogenesis.

J Clin Endocrinol Metab

November 2024

Department of Endocrinology, Key Laboratory of Endocrinology, National Commission of Health, State Key Laboratory for Complex, Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science, Beijing 100730, China.

Context: Primary hypertrophic osteoarthropathy (PHO) is a rare genetic disorder characterized by skeletal and skin abnormalities. Genetic defects in prostaglandin E2 (PGE2) metabolism are known to cause PHO. However, the global impact and clinical significance of eicosanoids and oxylipins beyond PGE2 remain to be elucidated.

View Article and Find Full Text PDF

An Unusual Case of Gastric Multiple Lesions With Skin and Joint Abnormalities.

Gastroenterology

November 2024

Department of Gastroenterology and Hepatology, West China Hospital, Sichuan University, Chengdu, China; Sichuan University-University of Oxford Huaxi Joint Centre for Gastrointestinal Cancer, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, China. Electronic address:

View Article and Find Full Text PDF
Article Synopsis
  • A 66-year-old male with recurrent stage IIIA non-small cell lung cancer (NSCLC) developed hypertrophic osteoarthropathy (HOA) before starting immunotherapy.
  • After receiving the immunotherapy drug durvalumab, the patient experienced significant relief from hand pain and complete resolution of his symptoms after five treatments.
  • This case is notable because it suggests durvalumab could help manage HOA in NSCLC patients, highlighting a need for additional research into how immune-checkpoint inhibitors interact with HOA and other related conditions.
View Article and Find Full Text PDF
Article Synopsis
  • * A patient with HOA secondary to lung adenocarcinoma presented with symptoms resembling rheumatoid arthritis, highlighting the need for careful diagnosis since antibodies typically associated with rheumatoid arthritis can be elevated in other conditions too.
  • * This case emphasizes the importance of considering HOA when diagnosing inflammatory arthritis in cancer patients, as proper identification and treatment of the underlying malignancy can significantly improve both rheumatologic and cancer-related outcomes.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!